LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the U.S. Food and Drug Administration (FDA) ...
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication of new data from a prospective, multicenter ...
obstruction of a June 2008 federal audit; charges were recorded in Q1 2011 * Says this final settlement also includes the resolution of a related qui tam category S&P 500 ekes out all-time closing ...
Orthofix Medical Inc. announced it received FDA pre-market approval for the AccelStim bone healing therapy class III device, which provides nonsurgical treatment for indicated fresh fractures and ...
Bone Growth Stimulator Market Report by TBRC covers the bone growth stimulator market drivers and restraints, size, major players, and the impact of COVID-19 LONDON ...
In 2021, the global bone growth stimulator market was estimated to be worth $1.89 billion USD. By 2022, the market is expected to be worth US$ 1.99 billion, representing a 5.3% increase year on year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results